{"id":"W4220752685","doi":"10.1016/j.annonc.2022.02.223","title":"VP2-2022: Prospective double-blind, randomized phase III ENGOT-EN5/GOG-3055/SIENDO study of oral selinexor/placebo as maintenance therapy after first-line chemotherapy for advanced or recurrent endometrial cancer","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Internal medicine; Carboplatin; Endometrial cancer; Clinical endpoint; Chemotherapy; Progression-free survival; Taxane; Oncology; Phases of clinical research; Gastroenterology; Proportional hazards model; Urology; Clinical trial; Cancer; Breast cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001483649,0.002206035,0.00309297,0.000535582,0.0004065512,0.001170036,0.001267996,0.001610556,0.008441571],"category_scores_gemma":[0.0009051437,0.0008441202,0.001292685,0.0003850212,0.00137681,0.001212833,0.0003695019,0.003327687,0.001634286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007681499,"about_ca_system_score_gemma":0.001287532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001493966,"about_ca_topic_score_gemma":0.003668197,"domain_scores_codex":[0.999629,0.0001796984,0.00001532273,0.00007199465,0.00002818835,0.00007569609],"domain_scores_gemma":[0.9994872,0.00009295023,0.000088013,0.00004760632,0.00002766026,0.0002565775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9652309,0.009595478,0.0004254718,0.0005224164,0.0007746089,0.00003190135,0.00004280572,0.0004947807,0.004894374,0.0002149817,0.001315858,0.01645627],"study_design_scores_gemma":[0.9438029,0.05304776,0.001206801,0.00001891267,0.000251106,0.00002296976,0.00002130842,0.0003544956,0.0004982423,0.00009661909,0.0006651018,0.00001381735],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811168,0.004880525,0.00125417,0.0007061167,0.0006201403,0.003596491,0.002861957,0.0004212085,0.004542501],"genre_scores_gemma":[0.972059,0.003596217,0.002530831,0.001805642,0.000456359,0.004800981,0.003588053,0.0001058172,0.01105724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008441571,"threshold_uncertainty_score":0.02823985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1171115887024021,"score_gpt":0.4570379121618395,"score_spread":0.3399263234594374,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}